Literature DB >> 17488790

Postprandial lipemia associates with liver fat content.

Niina Matikainen1, Sakari Mänttäri, Jukka Westerbacka, Satu Vehkavaara, Nina Lundbom, Hannele Yki-Järvinen, Marja-Riitta Taskinen.   

Abstract

CONTEXT/
OBJECTIVE: Postprandial lipemia and low adiponectin represent novel risk factors for vascular disease. This study aimed to determine whether liver fat content and adiponectin are predictors of postprandial triglyceride (TG)-rich lipoproteins (TRL). PATIENTS/
INTERVENTIONS: Twenty-nine men were allocated into subgroups with either low (< or =5%) or high (>5%) liver fat measured with magnetic resonance proton spectroscopy. Subjects underwent an oral fat tolerance test with measurements of postprandial TG, cholesterol, apolipoprotein B-48 (apoB-48), and apoB-100 in TRL fractions, a euglycemic hyperinsulinemic clamp, and determination of abdominal fat volumes by magnetic resonance imaging.
RESULTS: Subjects with high liver fat displayed increased response of postprandial lipids in plasma, chylomicron, and very-low-density lipoprotein 1 (VLDL1) (Svedberg flotation rate 60-400) fractions. Liver fat correlated positively with postprandial responses (area under the curve) of TG (r = 0.597; P = 0.001), cholesterol (r = 0.546; P = 0.002), apoB-48 (r = 0.556; P = 0.002), and apoB-100 (r = 0.42; P = 0.023) in the VLDL1 fraction. Respective incremental areas under the curve correlated significantly with liver fat. Fasting adiponectin levels were inversely correlated with both postprandial lipids and liver fat content. Liver fat remained the only independent correlate in a multiple linear regression analysis for chylomicron and VLDL1 responses.
CONCLUSIONS: Liver fat content is a close correlate of postprandial lipids predicting the responses of TRL in chylomicrons and VLDL1 better than measures of glucose metabolism or body adiposity. Low adiponectin concentration is closely linked to high liver fat content and impaired TRL metabolism. High liver fat content associated with postprandial lipemia represents potential risk factors for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488790     DOI: 10.1210/jc.2007-0187

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Postprandial Metabolic Responses Differ by Age Group and Physical Activity Level.

Authors:  S R Emerson; S P Kurti; E M Emerson; B J Cull; K Casey; M D Haub; S K Rosenkranz
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

2.  Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy.

Authors:  Boris Guiu; Elodie Crevisy-Girod; Christine Binquet; Laurence Duvillard; David Masson; Côme Lepage; Samia Hamza; Denis Krausé; Bruno Verges; Anne Minello; Jean-Pierre Cercueil; Patrick Hillon; Jean-Michel Petit
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

3.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

4.  Postprandial lipemia in the elderly involves increased incorporation of ingested fat in plasma free fatty acids and small (Sf 20-400) triglyceride-rich lipoproteins.

Authors:  Guilherme M Puga; Christian Meyer; Sarah Everman; Lawrence J Mandarino; Christos S Katsanos
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

5.  Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content.

Authors:  Sven Haufe; Stefan Engeli; Petra Budziarek; Wolfgang Utz; Jeanette Schulz-Menger; Mario Hermsdorf; Susanne Wiesner; Christoph Otto; Verena Haas; Armin de Greiff; Friedrich C Luft; Michael Boschmann; Jens Jordan
Journal:  Diabetes       Date:  2010-03-31       Impact factor: 9.461

6.  Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.

Authors:  Laura G Sánchez-Lozada; Wei Mu; Carlos Roncal; Yuri Y Sautin; Manal Abdelmalek; Sirirat Reungjui; MyPhuong Le; Takahiko Nakagawa; Hui Y Lan; Xuequing Yu; Richard J Johnson
Journal:  Eur J Nutr       Date:  2009-07-22       Impact factor: 5.614

7.  Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.

Authors:  Mohammad S Siddiqui; Michael Fuchs; Michael O Idowu; Velimir A Luketic; Sherry Boyett; Carol Sargeant; Richard T Stravitz; Puneet Puri; Scott Matherly; Richard K Sterling; Melissa Contos; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2014-10-13       Impact factor: 11.382

Review 8.  Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

Authors:  G Targher; F Marra; G Marchesini
Journal:  Diabetologia       Date:  2008-09-02       Impact factor: 10.122

Review 9.  Triglycerides as vascular risk factors: new epidemiologic insights.

Authors:  William B Kannel; Ramachandran S Vasan
Journal:  Curr Opin Cardiol       Date:  2009-07       Impact factor: 2.161

Review 10.  Gender differences in insulin resistance, body composition, and energy balance.

Authors:  Eliza B Geer; Wei Shen
Journal:  Gend Med       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.